Cost, benefits, safety and medication adherence of anti-TB medicine in patients of drug-resistant tuberculosis in major hospital of South Gujarat
Not Applicable
- Conditions
- Health Condition 1: A150- Tuberculosis of lung
- Registration Number
- CTRI/2024/04/066018
- Lead Sponsor
- ot applicable
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Adult (=18 years of age) of any gender on BDQ-based regimen and other regimen for DR-TB
Exclusion Criteria
Patients not willing to participate
Drug resistant TB patient on anti-retroviral therapy
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cost effectiveness analysis outcome in natural units of effectiveness <br/ ><br>Cost minimization in monetary value <br/ ><br>Cost utility in QALY <br/ ><br>Cost benefit in DALY <br/ ><br>Safety and adherence of the DR-TB regimen in DR-TB PatientsTimepoint: Cost effectiveness analysis outcome in natural units of effectiveness 12 months <br/ ><br>Cost minimization in monetary value 12 months <br/ ><br>Cost utility in QALY 12 months <br/ ><br>Cost benefit in DALY 12 months <br/ ><br>Safety and adherence of the DR-TB regimen in DR-TB Patients 12 months
- Secondary Outcome Measures
Name Time Method not applicable as its single outcome studyTimepoint: not applicable